These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12885791)

  • 1. Urotensin II acts centrally to increase epinephrine and ACTH release and cause potent inotropic and chronotropic actions.
    Watson AM; Lambert GW; Smith KJ; May CN
    Hypertension; 2003 Sep; 42(3):373-9. PubMed ID: 12885791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac actions of central but not peripheral urotensin II are prevented by beta-adrenoceptor blockade.
    Hood SG; Watson AM; May CN
    Peptides; 2005 Jul; 26(7):1248-56. PubMed ID: 15949643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central cardiovascular action of urotensin II in spontaneously hypertensive rats.
    Lin Y; Tsuchihashi T; Matsumura K; Fukuhara M; Ohya Y; Fujii K; Iida M
    Hypertens Res; 2003 Oct; 26(10):839-45. PubMed ID: 14621188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular actions of frog urotensin II in the frog, Rana catesbeiana.
    Yano K; Hicks JW; Vaudry H; Conlon JM
    Gen Comp Endocrinol; 1995 Jan; 97(1):103-10. PubMed ID: 7713374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of central urotensin II on heart rate, blood pressure and brain Fos immunoreactivity in conscious rats.
    Watson AM; McKinley MJ; May CN
    Neuroscience; 2008 Jul; 155(1):241-9. PubMed ID: 18597948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACTH-suppressive and vasodilator actions of adrenomedullin in conscious sheep.
    Parkes DG; May CN
    J Neuroendocrinol; 1995 Dec; 7(12):923-9. PubMed ID: 8745270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urotensin II, a novel peptide in central and peripheral cardiovascular control.
    Watson AM; May CN
    Peptides; 2004 Oct; 25(10):1759-66. PubMed ID: 15476943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No effect on central or peripheral blood pressure of systemic urotensin II infusion in humans.
    Affolter JT; Newby DE; Wilkinson IB; Winter MJ; Balment RJ; Webb DJ
    Br J Clin Pharmacol; 2002 Dec; 54(6):617-21. PubMed ID: 12492609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central cardiovascular action of urotensin II in conscious rats.
    Lin Y; Tsuchihashi T; Matsumura K; Abe I; Iida M
    J Hypertens; 2003 Jan; 21(1):159-65. PubMed ID: 12544448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular actions of trout urotensin II in the conscious trout, Oncorhynchus mykiss.
    Le Mevel JC; Olson KR; Conklin D; Waugh D; Smith DD; Vaudry H; Conlon JM
    Am J Physiol; 1996 Nov; 271(5 Pt 2):R1335-43. PubMed ID: 8945972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of ERK and Rho kinase pathways in central pressor action of urotensin II.
    Lin Y; Matsumura K; Tsuchihashi T; Fukuhara M; Fujii K; Iida M
    J Hypertens; 2004 May; 22(5):983-8. PubMed ID: 15097239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular actions of dogfish urotensin II in the dogfish Scyliorhinus canicula.
    Hazon N; Bjenning C; Conlon JM
    Am J Physiol; 1993 Sep; 265(3 Pt 2):R573-6. PubMed ID: 8214148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticotropin-releasing factor, sauvagine, and urotensin I: effects on blood flow.
    Lenz HJ; Fisher LA; Vale WW; Brown MR
    Am J Physiol; 1985 Jul; 249(1 Pt 2):R85-90. PubMed ID: 3874558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional heterogeneity in the haemodynamic responses to urotensin II infusion in relation to UT receptor localisation.
    Gardiner SM; March JE; Kemp PA; Maguire JJ; Kuc RE; Davenport AP; Bennett T
    Br J Pharmacol; 2006 Mar; 147(6):612-21. PubMed ID: 16314853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of human urotensin-II infusion on hemodynamics and cardiac function.
    Hassan GS; Chouiali F; Saito T; Hu F; Douglas SA; Ao Z; Willette RN; Ohlstein EH; Giaid A
    Can J Physiol Pharmacol; 2003 Feb; 81(2):125-8. PubMed ID: 12710525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urotensin I, a CRF-like neuropeptide, stimulates acth release from the teleost pituitary.
    Fryer J; Lederis K; Rivier J
    Endocrinology; 1983 Dec; 113(6):2308-10. PubMed ID: 6315348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged systemic and regional haemodynamic effects of intracerebroventricular angiotensin II in conscious sheep.
    May CN
    Clin Exp Pharmacol Physiol; 1996; 23(10-11):878-84. PubMed ID: 8911729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac inotropic actions of urocortin in conscious sheep.
    Parkes DG; Vaughan J; Rivier J; Vale W; May CN
    Am J Physiol; 1997 May; 272(5 Pt 2):H2115-22. PubMed ID: 9176276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular actions of the stress-related neurohormonal peptides, corticotropin-releasing factor and urotensin-I in the trout Oncorhynchus mykiss.
    Le Mével JC; Mimassi N; Lancien F; Mabin D; Conlon JM
    Gen Comp Endocrinol; 2006 Mar; 146(1):56-61. PubMed ID: 16386738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urotensin-II: a novel systemic hypertensive factor in the cat.
    Behm DJ; Doe CP; Johns DG; Maniscalco K; Stankus GP; Wibberley A; Willette RN; Douglas SA
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Mar; 369(3):274-80. PubMed ID: 14985938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.